» Articles » PMID: 18509765

P. Aeruginosa Biofilms in CF Infection

Overview
Date 2008 May 30
PMID 18509765
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa is an opportunistic pathogen of immunocompromised hosts. In cystic fibrosis (CF), P. aeruginosa causes acute and chronic lung infections that result in significant morbidity and mortality. P. aeruginosa possesses several traits that contribute to its ability to colonize and persist in acute and chronic infections. These include high resistance to antimicrobials, ability to form biofilms, plethora of virulence products, and metabolic versatility. In P. aeruginosa, a cell-to-cell communication process termed quorum sensing (QS) regulates many of these factors that contribute to its pathogenesis. Recent evidence suggests that the CF lung environment presents a specialized niche for P. aeruginosa. The relationship of P. aeruginosa QS, biofilm formation, and the CF lung environment is discussed.

Citing Articles

Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infections.

Fakhoury N, Mansour S, Abdel-Halim M, Hamed M, Empting M, Boese A Drug Deliv Transl Res. 2024; 15(4):1193-1209.

PMID: 39048783 PMC: 11870967. DOI: 10.1007/s13346-024-01662-2.


Non-interchangeable functions of efflux transporters of in survival under infection-associated stress.

Adamiak J, Ajmal L, Zgurskaya H J Bacteriol. 2024; 206(7):e0005424.

PMID: 38874367 PMC: 11323973. DOI: 10.1128/jb.00054-24.


Exploring marine-derived bioactive compounds for dual inhibition of Pseudomonas aeruginosa LpxA and LpxD: integrated bioinformatics and cheminformatics approaches.

Alamri M, Prinsa , Kawsar S, Saha S Mol Divers. 2024; 29(2):1033-1047.

PMID: 38780832 DOI: 10.1007/s11030-024-10888-8.


: a model for host-associated biofilm formation.

Fung B, Esin J, Visick K J Bacteriol. 2024; 206(2):e0037023.

PMID: 38270381 PMC: 10882983. DOI: 10.1128/jb.00370-23.


Changes in the expression of mexB, mexY, and oprD in clinical Pseudomonas aeruginosa isolates.

Matsumoto Y, Yamasaki S, Hayama K, Iino R, Noji H, Yamaguchi A Proc Jpn Acad Ser B Phys Biol Sci. 2024; 100(1):57-67.

PMID: 38199247 PMC: 10864171. DOI: 10.2183/pjab.100.006.


References
1.
Ramsey D, Wozniak D . Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol. 2005; 56(2):309-22. DOI: 10.1111/j.1365-2958.2005.04552.x. View

2.
Tang H, Kays M, Prince A . Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun. 1995; 63(4):1278-85. PMC: 173147. DOI: 10.1128/iai.63.4.1278-1285.1995. View

3.
Rahme L, Ausubel F, Cao H, Drenkard E, Goumnerov B, Lau G . Plants and animals share functionally common bacterial virulence factors. Proc Natl Acad Sci U S A. 2000; 97(16):8815-21. PMC: 34017. DOI: 10.1073/pnas.97.16.8815. View

4.
Pamp S, Tolker-Nielsen T . Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol. 2007; 189(6):2531-9. PMC: 1899385. DOI: 10.1128/JB.01515-06. View

5.
Leid J, Willson C, Shirtliff M, Hassett D, Parsek M, Jeffers A . The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol. 2005; 175(11):7512-8. DOI: 10.4049/jimmunol.175.11.7512. View